Michael Douglas Taylor is Director at Deciphera Pharmaceuticals, Inc. (DCPH). They have made 23 open-market trades across 1 company since 2019, most recently 2021-05-03.
CIK 0001494875
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DCPH | 2,354 | $60K |
Shares reported on the most recent Form 4, priced at the 2021-05-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DCPH | SELL | 2021-05-03 | 2021-05-05 | $46.10 | $369K | -7.8% | -12.1% | -21.2% |
| DCPH | SELL | 2021-04-01 | 2021-04-06 | $45.62 | $593K | +6.2% | -22.0% | -20.2% |
| DCPH | SELL | 2021-03-01 | 2021-03-03 | $43.99 | $655K | -3.5% | +4.0% | -24.2% |
| DCPH | SELL | 2021-02-01 | 2021-02-03 | $45.20 | $687K | -1.2% | -11.6% | -10.5% |
| DCPH | SELL | 2021-01-04 | 2021-01-06 | $56.45 | $2.1M | -8.1% | -4.6% | -17.4% |
| DCPH | SELL | 2020-12-01 | 2020-12-03 | $60.89 | $2.3M | -2.8% | -2.2% | -23.6% |
| DCPH | SELL | 2020-11-04 | 2020-11-06 | $64.80 | $1.9M | +1.7% | -12.8% | -19.3% |
| DCPH | SELL | 2020-11-02 | 2020-11-04 | $57.64 | $2.7M | +2.1% | -11.6% | -24.0% |
| DCPH | SELL | 2020-10-01 | 2020-10-05 | $51.61 | $12.9M | +0.8% | +16.2% | +2.1% |
| DCPH | SELL | 2020-07-01 | 2020-07-06 | $57.28 | $12.1M | -4.1% | -12.9% | -0.1% |
| DCPH | SELL | 2020-04-28 | 2020-04-30 | $56.73 | $2.3M | -7.8% | +8.1% | -17.9% |
| DCPH | SELL | 2020-04-17 | 2020-04-21 | $46.67 | $2.2M | +11.3% | +26.8% | +12.6% |
| DCPH | SELL | 2020-04-14 | 2020-04-16 | $46.71 | $104K | +25.7% | +23.6% | +19.4% |
| DCPH | SELL | 2020-04-01 | 2020-04-03 | $37.57 | $5.6M | +12.0% | +45.2% | +46.3% |
| DCPH | SELL | 2020-01-02 | 2020-01-06 | $57.75 | $11.1M | +17.6% | +17.6% | -26.1% |
| DCPH | SELL | 2019-11-01 | 2019-11-05 | $45.02 | $338K | +6.1% | +11.5% | +41.7% |
| DCPH | SELL | 2019-09-11 | 2019-09-13 | $34.97 | $1.6M | -6.0% | -9.6% | +60.1% |
| DCPH | SELL | 2019-09-03 | 2019-09-05 | $36.26 | $272K | -2.4% | -9.8% | +38.6% |
| DCPH | SELL | 2019-08-13 | 2019-08-13 | $40.77 | $917K | -0.7% | +0.4% | +33.7% |
| DCPH | SELL | 2019-08-13 | 2019-08-13 | $40.60 | $1.7M | -0.7% | +0.4% | +33.7% |
| DCPH | SELL | 2019-02-14 | 2019-02-19 | $28.56 | $410K | -2.2% | -16.4% | -22.3% |
| DCPH | SELL | 2019-02-13 | 2019-02-14 | $28.00 | $75K | +5.3% | -9.3% | -16.4% |
| DCPH | SELL | 2019-02-12 | 2019-02-14 | $28.00 | $80K | +5.3% | -9.3% | -16.4% |
| DCPH | SELL · 10b5-1 | 2019-02-05 | 2019-02-07 | $28.01 | $48K | +5.5% | -0.8% | -11.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.